Compute Health (NYSE:CPUH) announced this afternoon that its shareholders approved its combination with weight-loss medtech firm Allurion at a special meeting held earlier today.
Approximately 99.8% of the votes cast on the business combination proposals by holders of Compute Health’s common stock, representing approximately 87.7% of the company’s outstanding common stock, voted to approve the deal, including approximately 58.2% of the outstanding shares of Class A common stock.
Although Compute Health has not yet disclosed redemption figures, the SPAC already saw 89.31% of its trust redeemed during an extension meeting in December. Nonetheless, the parties expect to close the deal on or about August 1, subject to the satisfaction of customary closing conditions.
Following the closing, the combined company will operate as Allurion Technologies, Inc. and will be listed on the NYSE, with its common stock and public warrants trading under the new ticker symbols “ALUR” and “ALUR WS,” respectively.
Today’s announcement follows yesterday’s approval from warrant holders to amend Compute Health’s warrant agreement. Compute Health inked its $500 million business combination with Allurion earlier this year in February. Natick, Massachusetts-based Allurion makes a swallowable balloon that inflates in patients’ stomachs to reduce space for incoming food for weight loss purposes while serving as an IoT tracker of certain health metrics.
Globa Terra Acquisition Corporation (NASDAQ:GTERU) announced the pricing of its $152 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “GTERU”, Wednesday, July 9, 2025. The new SPAC plans to mount a search for a target in the agriculture, agtech or biotech sectors with an emphasis on water...
M3-Brigade V (NASDAQ:MBAV) has entered into a definitive agreement to combine with crypto treasury firm ReserveOne, assembling about $1 billion in equity funding. ReserveOne is setting up a diversified Bitcoin and digital asset treasury with a portion of its investments going towards blockchain infrastructure and venture raises. The combined company is expected to trade on...
At the SPAC of Dawn As the SPAC market has warmed in 2025, only 21 of the 70 SPACs (30%) that have IPO’d thus far have overfunded their trusts to draw in investors and none of these funded to more than 101%. By contrast, 87% of 2023 SPACs were overfunded – some to as high...
Emmis Acquisition Corporation (NASDAQ:EMISU) has filed for a $100 million SPAC to take a look at the manufacturing sector after a few unique wrinkles in their IPO process. Initial investors are set to receive one right to a 1/10 share in each unit purchased and the SPAC will have 18 months to complete a business...
Chenghe III (NASDAQ:CHEC.U) has filed for a $110 million SPAC to continue the team’s growing series while turning to a new underwriter. The new SPAC is offering investors a 1/2 warrant in each unit and no overfunding of the trust, but it will need to complete a business combination within 18 months of its IPO...